Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03605693 · ClinicalTrials.gov registry record · NA

Early Psychological Intervention to Prevent Cardiovascular Event-Induced PTSD (REACH Sub-study)

A NA study, sponsored by Columbia University.

Terminated
Registry status
NA
Development phase
10
Enrollment target

NCT03605693 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03605693, a NA study, was terminated before completion, sponsored by Columbia University.

TERMINATED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The overall purpose of this project is to determine the feasibility of conducting a randomized clinical trial that compares written exposure therapy with usual care among patients at risk for cardiovascular event-induced PTSD. Patients hospitalized with acute cardiovascular events, including strokes, heart attacks, and cardiac arrest are at risk of developing post-traumatic stress disorder (PTSD) due to the trauma of the acute medical event. The goal of this study is to test the feasibility of conducting a randomized trial involving a psychological intervention to prevent the development of PTSD symptoms in patients at risk for PTSD. Patients who are admitted with these acute cardiovascular events will first be screened for PTSD risk factors while in-hospital after the index event. These risk factors will include elevated threat perceptions at the time of presentation to the hospital or early symptoms of PTSD due to the cardiovascular event. Patients at elevated risk for PTSD will then be randomized to the intervention group or usual care. Those assigned to the intervention will participate in 5 sessions of written exposure therapy in which they are asked to write about the experience of their cardiovascular event with guidance from a trained study clinician. At 1 month after discharge, all patients will be contacted by phone to complete a questionnaire that assesses PTSD symptoms related to the cardiovascular event. Descriptive statistics will be used to understand the feasibility of testing the written exposure therapy intervention as part of a larger, fully powered clinical trial.

Interventions

  • BEHAVIORAL Written Exposure Therapy

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2018-08-01
Est. Completion 2019-12-31
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03605693

The ClinicalTrials.gov registry entry for NCT03605693 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Written Exposure Therapy is the first listed.

NCT03605693 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03605693 about?

NCT03605693 is a clinical study titled "Early Psychological Intervention to Prevent Cardiovascular Event-Induced PTSD (REACH Sub-study)". The overall purpose of this project is to determine the feasibility of conducting a randomized clinical trial that compares written exposure therapy with usual care among patients at risk for cardiovascular event-induced PTSD. Patients hospitalized with acute cardiovascular events, including stroke...

What is the current status of trial NCT03605693?

This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2018-08-01. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT03605693?

The interventions under investigation include: Written Exposure Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03605693?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.